Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
103 participants
OBSERVATIONAL
2020-05-13
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote By Default 2: Optimising the Remote-by-default Model in the United Kingdom (UK) General Practice
NCT05244941
Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1
NCT05813652
Burn Out Among Medical Family Doctors
NCT04242862
Health-related Quality of Life and Long COVID
NCT05552612
Assessing People's Hospital Outpatient Appointment Preferences in the United Kingdom
NCT04536259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Key deliverables:
At least two evidence-based assessment tools: qualitative (questions for remote assessment of breathlessness) and quantitative (a COVID-19-specific early warning score)
Transferable lessons about how to achieve rapid spread and scale-up, spread in real time through our extensive intersectoral networks
Strengthened infrastructure for supporting digital innovation in the NHS
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote assessment tools
Qualitative methods: semi-structured interviews for approx 40 front line clinical practitioners
No interventions assigned to this group
RECAP early warning score
Development of disease specific early warning score, building on earlier work through literature review and NEWS2 score
No interventions assigned to this group
Implementation/Scale up case studies
Study of implementation and scale up of remote-by-default at four different UK sites
No interventions assigned to this group
Infrastructure strengthening
Theory and data driven change effort involving policymakers, regulators, professional bodies, industry, patients and citizens with a view to overcoming interacting issues impacting success of digital projects.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Aged 18 years or above
Staff involved in delivering remote-by-default services in the frontline or 'back offices'
Patients/carers who have crossed paths with primary care services during the Covid pandemic.
Pharmacy case studies:
Staff involved in delivering remote pharmacist consultation services in the frontline or 'back offices'
Patients/carers who have crossed paths with community pharmacy primary care services during the COVID-19 pandemic.
Patients who have remote primary care consultation regarding symptoms associated with COVID-19 and their clinicians (based in Oxford/Thames Valley) who have agreed to participate in the study
Patients that have experienced self-reported 'long Covid' symptoms (for patient only focus groups)
Clinicians that have experienced self-reported 'long Covid' symptoms (for clinician only focus groups)
Exclusion Criteria
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Plymouth
OTHER
Nuffield Trust
UNKNOWN
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oxford
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fiorentino F, Prociuk D, Espinosa Gonzalez AB, Neves AL, Husain L, Ramtale SC, Mi E, Mi E, Macartney J, Anand SN, Sherlock J, Saravanakumar K, Mayer E, de Lusignan S, Greenhalgh T, Delaney BC. An Early Warning Risk Prediction Tool (RECAP-V1) for Patients Diagnosed With COVID-19: Protocol for a Statistical Analysis Plan. JMIR Res Protoc. 2021 Oct 5;10(10):e30083. doi: 10.2196/30083.
Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec 20;20(1):1144. doi: 10.1186/s12913-020-06001-y.
Greenhalgh T, Thompson P, Weiringa S, Neves AL, Husain L, Dunlop M, Rushforth A, Nunan D, de Lusignan S, Delaney B. What items should be included in an early warning score for remote assessment of suspected COVID-19? qualitative and Delphi study. BMJ Open. 2020 Nov 12;10(11):e042626. doi: 10.1136/bmjopen-2020-042626.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
283196
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.